Downloads: 6
Georgia | Virology Science | Volume 12 Issue 10, October 2023 | Pages: 1116 - 1120
Therapeutic Efficacy of Isoflavone - Forte against HIV: A Case Series
Abstract: Background: Despite the effectiveness of current HIV therapies, such as highly active antiretroviral therapy (HAART), eradicating latent viral reservoirs remains a challenge. Isoflavone-Forte, a formulation rich in viral replication blockers, anti-inflammatory, and anticancer agents, may offer a solution. This study investigates its efficacy in HIV-positive patients with a history of tuberculosis. Methods: Five patients were treated with Isoflavone-Forte derived from Polygonum cuspidatum resin, extracted via a chromatographic separation method. Results: All patients experienced significant reductions in viral load and improvements in immune parameters. No side effects were reported during or after treatment. Conclusions: These results suggest that Isoflavone-Forte effectively mitigates HIV infection, improving viral load and immune parameters, with no observed side effects. While these outcomes show promise for Isoflavone-Forte as a beneficial therapeutic strategy for HIV, further studies are necessary for validation.luable insights for improving individualized care in NSCLC.
Keywords: Isoflavone-Forte, Polygonum cuspidatum,HIV treatment, SARS-CoV-2, patients with HIV and tuberculosis, Disease stabilization
How to Cite?: A. Tavartkiladze, G. Simonia, N. Okrostsvaridze, G.Tavartkiladze, "Therapeutic Efficacy of Isoflavone - Forte against HIV: A Case Series", Volume 12 Issue 10, October 2023, International Journal of Science and Research (IJSR), Pages: 1116-1120, https://www.ijsr.net/getabstract.php?paperid=SR231014020316, DOI: https://dx.doi.org/10.21275/SR231014020316